Position in JNJ
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$245,586,179
-$273,636,056 QoQ
Shares Held
1,004,689
-60.0% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 69.19574116965549.ToString("F0")%
Shared 0.ToString("F0")%
None 30.804258830344516.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $2,760,772,587 across 11 Drug Manufacturers - General names. JNJ ranks #6 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
4,652,246 | $917,515,956 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
8,872,779 | $538,134,046 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,936,330 | $353,211,135 | |
| 4 | NVO |
Novo Nordisk A S
|
7,827,491 | $287,660,294 | |
| 5 | LLY |
ELI LILLY & Co
|
282,798 | $260,109,116 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
1,004,689 | $245,586,179 | |
| 7 | GSK |
GSK plc
|
1,621,397 | $89,484,900 | |
| 8 | ABBV |
AbbVie Inc.
|
122,181 | $26,573,145 |
All Filings in JNJ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $245,586,179 | 1,004,689 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $519,222,235 | 2,508,926 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $429,149,027 | 2,314,470 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $375,636,384 | 2,459,158 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $547,496,879 | 3,301,356 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $342,266,369 | 2,366,660 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $186,831,843 | 1,152,856 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $121,037,434 | 828,116 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $111,786,545 | 706,660 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $6,471,879 | 41,553 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $188,257,265 | 1,214,563 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $140,561,111 | 795,704 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $15,152,456 | 92,755 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,299,383 | 29,854 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,179,219,300 | 6,653,610 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $829,343,596 | 4,847,978 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $856,659,308 | 5,304,392 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,141,445,075 | 6,928,767 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,479,970,763 | 9,004,994 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $994,017,903 | 6,316,037 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,151,478,713 | 7,734,274 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,109,117,871 | 7,886,780 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $926,752,095 | 7,067,430 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||